Growth Metrics

Koninklijke Philips (PHG) Return on Capital Employed (2009 - 2026)

Koninklijke Philips' quarterly Return on Capital Employed came in at 7.62% in Q1 2026, up 49.0% year-on-year from 5.12% in Q1 2025, and up 4.54% quarter-over-quarter from 7.29% in Q4 2025.

Koninklijke Philips has reported Return on Capital Employed for 10 years, with the latest figure at 7.62% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 49.0% year-over-year to 7.62%; the trailing twelve-month figure through Mar 2026 stood at 7.62% (up 49.0% YoY), and the FY2025 full-year result was 7.39%, up 489.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 7.62%, up from 7.29% in the prior quarter.
  • The five-year high for Return on Capital Employed was 9.87% in Q2 2025, with the low at 7.14% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.61%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.24%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 7.36%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 7.62%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.30%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 11.57%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 5.88%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.62%
Dec 31, 2025 7.29%
Sep 30, 2025 9.48%
Jun 30, 2025 9.87%
Mar 31, 2025 7.14%
Dec 31, 2017 6.92%
Sep 30, 2017 8.41%
Jun 30, 2017 8.17%
Mar 31, 2017 6.98%
Dec 31, 2016 6.99%
Sep 30, 2016 10.62%
Jun 30, 2016 8.89%
Mar 31, 2016 9.17%
Dec 31, 2015 8.80%
Sep 30, 2015 6.60%
Jun 30, 2015 9.18%
Mar 31, 2015 9.42%
Dec 31, 2014 11.46%
Jun 30, 2013 13.51%
Mar 31, 2013 12.11%
Dec 31, 2012 12.54%
Dec 31, 2010 10.90%
Dec 31, 2009 2.69%